The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

David J. Greenblatt

Tufts University School of Medicine

Tufts Medical Center

Department of Molecular Physiology and Pharmacology

Sackler Program in Pharmacology and Experimental Therapeutics

[email]@tufts.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Tufts University School of Medicine, Tufts Medical Center, Department of Molecular Physiology and Pharmacology, Sackler Program in Pharmacology and Experimental Therapeutics. 2012
  • Tufts University School of Medicine, Department of Molecular Physiology and Pharmacology, 136 Harrison Avenue, Boston MA 02111. 2012
  • Program in Pharmacology and Experimental Therapeutics, Department of Molecular Physiology and Pharmacology, Tufts University School of Medicine and Tufts Medical Center, Boston, USA. 2000 - 2011

References

  1. Pharmacokinetic evaluation of eszopiclone : clinical and therapeutic implications. Greenblatt, D.J., Zammit, G.K. Expert. Opin. Drug. Metab. Toxicol (2012) [Pubmed]
  2. Zolpidem for insomnia. Greenblatt, D.J., Roth, T. Expert. Opin. Pharmacother (2012) [Pubmed]
  3. Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon. Greenblatt, D.J., Harmatz, J.S., Walsh, J.K., Luthringer, R., Staner, L., Otmani, S., Nedelec, J.F., Francart, C., Parent, S.J., Staner, C. Biopharm. Drug. Dispos (2011) [Pubmed]
  4. Mechanism of cytochrome P450-3A inhibition by ketoconazole. Greenblatt, D.J., Zhao, Y., Venkatakrishnan, K., Duan, S.X., Harmatz, J.S., Parent, S.J., Court, M.H., von Moltke, L.L. J. Pharm. Pharmacol. (2011) [Pubmed]
  5. Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro. Greenblatt, D.J., Venkatakrishnan, K., Harmatz, J.S., Parent, S.J., von Moltke, L.L. Xenobiotica (2010) [Pubmed]
  6. Analysis of drug interactions involving fruit beverages and organic anion-transporting polypeptides. Greenblatt, D.J. J. Clin. Pharmacol (2009) [Pubmed]
  7. Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase. Greenblatt, D.J., Peters, D.E., Oleson, L.E., Harmatz, J.S., MacNab, M.W., Berkowitz, N., Zinny, M.A., Court, M.H. Br. J. Clin. Pharmacol (2009) [Pubmed]
  8. Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs. Greenblatt, D.J., von Moltke, L.L. J. Clin. Pharmacol (2008) [Pubmed]
  9. Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. Greenblatt, D.J., Harmatz, J.S., Karim, A. J. Clin. Pharmacol (2007) [Pubmed]
  10. In vitro interactions of water-soluble garlic components with human cytochromes p450. Greenblatt, D.J., Leigh-Pemberton, R.A., von Moltke, L.L. J. Nutr. (2006) [Pubmed]
  11. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo. Greenblatt, D.J., Legangneux, E., Harmatz, J.S., Weinling, E., Freeman, J., Rice, K., Zammit, G.K. J. Clin. Pharmacol (2006) [Pubmed]
  12. Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution Test. Greenblatt, D.J., Gan, L., Harmatz, J.S., Shader, R.I. Br. J. Clin. Pharmacol (2005) [Pubmed]
  13. Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Greenblatt, D.J., Harmatz, J.S., von Moltke, L.L., Wright, C.E., Shader, R.I. Clin. Pharmacol. Ther. (2004) [Pubmed]
  14. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. Patki, K.C., Von Moltke, L.L., Greenblatt, D.J. Drug Metab. Dispos. (2003) [Pubmed]
  15. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice. Greenblatt, D.J., von Moltke, L.L., Harmatz, J.S., Chen, G., Weemhoff, J.L., Jen, C., Kelley, C.J., LeDuc, B.W., Zinny, M.A. Clin. Pharmacol. Ther. (2003) [Pubmed]
  16. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. Greenblatt, D.J., Harmatz, J.S., von Moltke, L.L., Wright, C.E., Durol, A.L., Harrel-Joseph, L.M., Shader, R.I. J. Pharmacol. Exp. Ther. (2000) [Pubmed]
  17. Alprazolam-ritonavir interaction: implications for product labeling. Greenblatt, D.J., von Moltke, L.L., Harmatz, J.S., Durol, A.L., Daily, J.P., Graf, J.A., Mertzanis, P., Hoffman, J.L., Shader, R.I. Clin. Pharmacol. Ther. (2000) [Pubmed]
  18. Differential impairment of triazolam and zolpidem clearance by ritonavir. Greenblatt, D.J., von Moltke, L.L., Harmatz, J.S., Durol, A.L., Daily, J.P., Graf, J.A., Mertzanis, P., Hoffman, J.L., Shader, R.I. J. Acquir. Immune Defic. Syndr. (2000) [Pubmed]
  19. Kinetics and dynamics of lorazepam during and after continuous intravenous infusion. Greenblatt, D.J., von Moltke, L.L., Ehrenberg, B.L., Harmatz, J.S., Corbett, K.E., Wallace, D.W., Shader, R.I. Crit. Care Med. (2000) [Pubmed]
 
WikiGenes - Universities